Indus Nephrology Private Limited
About Indus Nephrology Private Limited
Data last updated:
Indus Nephrology Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the diversified business activities segment of the business services sector. It was incorporated on 07 September 2016.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC305572.
The company had an authorised share capital of ₹20 Lakh and a paid-up capital of ₹16.1 Lakh. It was led by directors Upendra Raina and Kulwant Bir Singh Anand.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at 26/8 Basement Old Rajinder Nagar, Delhi, India – 110060.
As per the financials filed for FY 2021, the company reported a revenue of ₹14,800. For the same year it recorded a net loss of ₹32,680 (net margin -220.8%) and EBITDA of -₹32,680 (EBITDA margin -220.8%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address26/8 Basement Old Rajinder Nagar, Delhi, India – 110060
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Indus Nephrology Private Limited FY 2021 filings available
Indus Nephrology Private Limited reported revenue of ₹14,800 for FY 2021.
Financial Statement Summary of Indus Nephrology Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹32,680 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹32,680 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Indus Nephrology Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -220.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -220.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Indus Nephrology are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Indus Nephrology Private Limited
Indus Nephrology has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Upendra Raina | Director | 29 Dec 2016 | 9 Years 9 Months | As last reported |
| Kulwant Bir Singh Anand | Director | 07 Sep 2016 | 10 Years 1 Months | As last reported |
Peer Comparison of Indus Nephrology Private Limited
Indus Nephrology Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Crispr Healthcare Ventures Private Limited | ₹18,000 (FY 2024) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| D V Labs Private Limited | ₹15,624 (FY 2023) | •••• | •••• | -48.0% | •••• | Bangalore, Karnataka, India |
| Kunal Hospital and Diagnostics Pvt Ltd | ₹15,440 (FY 2025) | •••• | •••• | -100.0% | •••• | Ahmedabad, Gujarat, India |
| Ayushman Clinic Private Limited | ₹15,300 (FY 2022) | •••• | •••• | 22.0% | •••• | Patna, Bihar, India |
| Ahuja Infrastructure Private Limited | ₹14,993 (FY 2024) | •••• | •••• | -96.0% | •••• | Delhi, India |
| Indus Nephrology Private Limited this company | ₹14,800 (FY 2021) | •••• | •••• | •••• | Delhi, India | |
| Mobimeds Healthcare Private Limited | ₹14,130 (FY 2024) | •••• | •••• | -3.0% | •••• | Hindmotor, West Bengal, India |
| Sri Krishna Sai Diagnostic and Research Institute Private Limited | ₹13,231 (FY 2024) | •••• | •••• | -69.0% | •••• | Hyderabad, Telangana, India |
| Totipotentrx Cell Therapy Private Limited | ₹13,207 (FY 2023) | •••• | •••• | -38.0% | •••• | Gurugram, Haryana, India |
| Sanctus Bio Private Limited | ₹13,070 (FY 2024) | •••• | •••• | 15.0% | •••• | Hyderabad, Telangana, India |
| Shri Siddhivinayak Cath Lab Private Limited | ₹11,576 (FY 2020) | •••• | •••• | -99.0% | •••• | Karad, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Indus Nephrology by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Indus Nephrology Private Limited
Indus Nephrology Private Limited is audited by BHATIA BEHL & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BHATIA BEHL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Indus Nephrology Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Indus Nephrology Private Limited
Indus Nephrology Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Indus Nephrology Private Limited
Employment history and EPFO contributions of people linked to Indus Nephrology.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Indus Nephrology Private Limited
Indus Nephrology Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Upendra Raina ceased to be Additional Director on 28 Dec 2017.
Credit Ratings, Litigation & Regulatory Alerts for Indus Nephrology Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Indus Nephrology Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Indus Nephrology Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Indus Nephrology Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Indus Nephrology Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indus Nephrology Private Limited
Indus Nephrology has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Indus Nephrology was a private limited company based in Delhi, India. The company worked in miscellaneous business activities, within the business services industry. It was incorporated on 07 September 2016 and is registered under CIN U74999DL2016PTC305572. The company has been struck off by the Registrar of Companies and is no longer operational.
Indus Nephrology had 2 directors:
- Upendra Raina - Director
- Kulwant Bir Singh Anand - Director
The CIN (Corporate Identification Number) of Indus Nephrology is U74999DL2016PTC305572. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Indus Nephrology is at 268 Basement Old Rajinder Nagar, Delhi, India – 110060.
Indus Nephrology was incorporated on 07 September 2016. It is registered with the Registrar of Companies, Delhi.
Indus Nephrology reported revenue of ₹14,800 for FY 2021.
Indus Nephrology has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹16.1 Lakh.
Indus Nephrology reported a net loss of ₹32,680 (net margin -220.8%) and EBITDA of -₹32,680 (EBITDA margin -220.8%) for FY 2021, as per its filed financial statements.
Indus Nephrology operated in the business services industry, in the miscellaneous business activities segment. It worked in this industry before it was struck off.
No. Indus Nephrology is not listed on any stock exchange. It is an unlisted company.